37 results on '"Horoi, Mihaela"'
Search Results
2. Features of Mild-to-Moderate COVID-19 Patients With Dysphonia
- Author
-
Lechien, Jerome R., Chiesa-Estomba, Carlos M., Cabaraux, Pierre, Mat, Quentin, Huet, Kathy, Harmegnies, Bernard, Horoi, Mihaela, Le Bon, Serge Daniel, Rodriguez, Alexandra, Dequanter, Didier, Hans, Stéphane, Crevier-Buchman, Lise, Hochet, Baptiste, Distinguin, Lea, Chekkoury-Idrissi, Younes, Circiu, Marta, El Afia, Fahd, Barillari, Maria Rosaria, Cammaroto, Giovanni, Fakhry, Nicolas, Michel, Justin, Radulesco, Thomas, Martiny, Delphine, Lavigne, Philippe, Jouffe, Lionel, Descamps, Géraldine, Journe, Fabrice, Trecca, Eleonora M.C., Hsieh, Julien, Delgado, Irene Lopez, Calvo-Henriquez, Christian, Vergez, Sebastien, Khalife, Mohamad, Molteni, Gabriele, Mannelli, Giuditta, Cantarella, Giovanna, Tucciarone, Manuel, Souchay, Christel, Leich, Pierre, Ayad, Tareck, and Saussez, Sven
- Published
- 2022
- Full Text
- View/download PDF
3. Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients
- Author
-
Le Bon, Serge-Daniel, Pisarski, Nathalie, Verbeke, Justine, Prunier, Léa, Cavelier, Gaëtan, Thill, Marie-Paule, Rodriguez, Alexandra, Dequanter, Didier, Lechien, Jérôme R., Le Bon, Olivier, Hummel, Thomas, and Horoi, Mihaela
- Published
- 2021
- Full Text
- View/download PDF
4. Patients with acid, high-fat and low-protein diet have higher laryngopharyngeal reflux episodes at the impedance-pH monitoring
- Author
-
Lechien, Jerome R., Bobin, Francois, Muls, Vinciane, Horoi, Mihaela, Thill, Marie-Paule, Dequanter, Didier, Rodriguez, Alexandra, and Saussez, Sven
- Published
- 2020
- Full Text
- View/download PDF
5. Validity and Reliability of the French Short Version of the Questionnaire of Olfactory Disorders-Negative Statements (sQOD-NS).
- Author
-
Leclercq, Céline, Chiesa-Estomba, Carlos M., Horoi, Mihaela, Le Bon, Serge D., Hans, Stephane, Distinguin, Lea, Chekkoury-Idrissi, Younes, Circiu, Marta P., Khalife, Mohamad, Saussez, Sven, and Lechien, Jérôme R.
- Subjects
EXPERIMENTAL design ,STATISTICS ,RESEARCH evaluation ,STATISTICAL reliability ,RESEARCH methodology ,RESEARCH methodology evaluation ,VISUAL analog scale ,MANN Whitney U Test ,SEVERITY of illness index ,CRONBACH'S alpha ,QUESTIONNAIRES ,QUALITY of life ,SMELL disorders ,DESCRIPTIVE statistics ,DATA analysis software ,DATA analysis ,STATISTICAL correlation ,FRENCH people - Abstract
Objective: To develop a French Short Version of the Questionnaire of Olfactory Disorders-Negative Statements (Fr-sQOD) to assess the quality of life impairments of patients with olfactory dysfunction (OD). Methods: Patients with OD and controls were enrolled from 2 academic centers. Individuals completed the Fr-sQOD, an OD visual analog scale severity, and the French version of the sinonasal outcome tool-22 (SNOT-22). Cronbach α was used to measure the internal consistency of Fr-sQOD. The reliability and the external validity of Fr-sQOD were assessed through a test–retest approach and by correlating Fr-sQOD with SNOT-22 scores, respectively. The external validity was assessed by correlation analysis between Fr-sQOD and the result of an assessment of the severity of OD on a visual analog scale. Results: Eighty patients completed the evaluations. The internal consistency was adequate (Cronbach α.96), and the test–retest reliability was high in the entire cohort (r
s = 0.877, P <.001). The correlation between Fr-sQOD total scores and the severity of OD was moderate but significant (rs = −0.431; P =.001) supporting an acceptable external validity. Patients with OD had a significantly higher score of Fr-sQOD than healthy individuals (P <.001), indicating a high internal validity. Conclusion: The Fr-sQOD is a reliable and valid self-administered tool in the evaluation of the impact of OD on quality of life of French-speaking patients. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
6. Laryngopharyngeal Reflux Patient Changes during the COVID-19 Quarantine.
- Author
-
Rodriguez, Alexandra, Steffens, Younes, Calvo-Henriquez, Christian, Mayo-Yáñez, Miguel, Horoi, Mihaela, and Lechien, Jerome R.
- Subjects
COVID-19 pandemic ,PERCEIVED Stress Scale ,PLANT-based diet ,HYPOPHARYNGEAL cancer ,PATIENT reported outcome measures ,QUARANTINE - Abstract
Background and Objective: To examine the effects of the lockdown on diet adherence and stress levels in patients with laryngopharyngeal reflux (LPR). Materials and Methods: Patients with a positive LPR diagnosis at the hypopharyngeal-esophageal impedance-pH monitoring were treated from a pre- to lockdown period with a 3-month high-protein, low-fat, alkaline, plant-based diet, with behavioral changes, and an association of pantoprazole (20 MG/d) and alginate (Gaviscon 3/d). The following patient-reported outcomes questionnaire and findings instrument were used: Reflux Symptom Score-12 (RSS-12) and Reflux Sign Assessment (RSA). At the posttreatment time, patients were invited to evaluate the impact of lockdown on diet adherence and stress management with a predefined grid of foods and beverages and the perceived stress scale (PSS), respectively. Results: Thirty-two patients completed the evaluations. RSS-12 and RSA significantly improved from baseline to 3-month posttreatment. Most patients experienced mild-to-severe stress levels at the end of the lockdown. The level of stress substantially increased in 11 patients (34%) due to the lockdown, while it did not change in 11 patients (44%). In 11 cases (34%), patients reported that the adherence to the anti-reflux diet was better than initially presumed thanks to the lockdown period, while 44% (N = 14) reported that the lockdown did not impact the adherence to a diet. PSS and RSS-12 were significantly correlated at the end of the pandemic (r
s = 0.681; p < 0.001). The increase in stress level was positively associated with the lack of adherence to diet (rs = 0.367; p = 0.039). Conclusions: During the lockdown, the diet habits of LPR patients were improved in one-third and unchanged in 44% of cases. The stress level was increased in one-third of patients, which was associated with an increase in symptom scores. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
7. Chronic maxillary atelectasis and silent sinus syndrome: two faces of the same clinical entity
- Author
-
de Dorlodot, Clotilde, Collet, Stephanie, Rombaux, Philippe, Horoi, Mihaela, Hassid, Sergio, and Eloy, Philippe
- Published
- 2017
- Full Text
- View/download PDF
8. Comparison of prevalence and evolution of COVID-19 olfactory disorders in patients infected by D614 (wild) and B.1.1.7. Alpha variant: a brief report.
- Author
-
Lechien, Jerome R., Wajsblat, Shannon, Horoi, Mihaela, Boscolo-Rizzo, Paolo, Le Bon, Serge D., Vaira, Luigi A., and Saussez, Sven
- Subjects
SMELL disorders ,SARS-CoV-2 ,COVID-19 ,VACCINATION status ,ORAL drug administration - Abstract
Objectives: To investigate the prevalence and the evolution of olfactory disorders (OD) related to coronavirus disease 2019 (COVID-19) in patients infected during the first and the second European waves. Methods: From March 2020 to October 2020, COVID-19 patients with OD were recruited and followed over the 12-month post-infection. The following data were collected: demographic, treatments, vaccination status, and olfactory function. Olfaction was assessed with the Olfactory Disorder Questionnaire (ODQ), and threshold, discrimination, and identification (TDI) test. Outcomes were compared between patients of the first wave (group 1: wild/D614G virus) and the second wave (group 2: B.1.1.7. Alpha variant) at 1-, 3- and 12-month post-infection. Results: Sixty patients completed the evaluations accounting for 33 and 27 patients in group 1 and 2, respectively. The 1-month TDI score (23.7 ± 5.3) was significantly lower in group 2 compared to group 1 (29.8 ± 8.7; p = 0.017). Proportion of normosmic patients at 1-month post-infection was significantly higher in group 1 compared to group 2 (p = 0.009). TDI scores only significantly increased from 1- to 3-month post-infection in anosmic and hyposmic patients. Focusing on There was a negative association between the 1-month ODQ and the 1-month TDI (r
s = − 0.493; p = 0.012). ODQ was a significant predictor of TDI scores at 3- and 12-month post-infection. The 12-month prevalence of parosmia was 60.6% in group 1 and 42.4% in group 2, respectively. There was no significant influence of oral corticosteroid treatment, adherence to an olfactory training and vaccination status on the olfactory outcomes. Conclusions: Patients of the second wave (Alpha B.1.1.7. variant) reported significant higher proportion of psychophysical test abnormalities at 1-month post-infection than patients infected during the first wave (D614G virus). [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
9. Influence of Age and Sex on Clinical and Therapeutic Features of Laryngopharyngeal Reflux.
- Author
-
Lechien, Jerome R., Carroll, Thomas L., Bobin, Francois, Muls, Vinciane, Rodriguez, Alexandra, Horoi, Mihaela, Dequanter, Didier, Crevier-Buchman, Lise, Hans, Stéphane, and Saussez, Sven
- Abstract
Objective: To explore the influence of age and sex on the clinical presentation and therapeutic response of patients with laryngopharyngeal reflux (LPR). Study Design: Prospective study. Setting: Prospective multicenter study of 271 patients with a diagnosis of LPR confirmed by impedance-pH monitoring. Methods: Patients were prescribed 6 months of diet changes and a combination of pantoprazole and/or alginate depending on the results of their impedance-pH results. The Reflux Symptom Score (RSS) and Reflux Sign Assessment (RSA) were collected at baseline and at 3 and 6 months posttreatment. Data were explored according to sex and age. Results: A total of 237 patients completed the evaluations (138 females). On the RSS, patients of the oldest group (>60 years) had lower symptom scores (throat pain, ear pain, odynophagia, chest pain, tongue burning, nausea, halitosis, and indigestion) and lower quality-of-life scores than younger individuals. RSS and RSA outcomes significantly improved from pretreatment to 3 months posttreatment in all groups. Scores on the RSS and RSA continued to improve from 3 to 6 months posttreatment in the elderly group. Females with LPR had a higher score on the RSS at baseline as compared with males. On the RSS, scores significantly improved after 3 months in males and females; however, they continued to improve from 3 to 6 months in the female group. Conclusion: Age and sex may influence the clinical presentation and pre- to posttreatment evolution of symptoms and findings. Age and sex differences could be considered in future therapeutic approaches to guide more effective personalized treatment plans for patients with LPR. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Effectiveness and safety of PRP on persistent olfactory dysfunction related to COVID-19.
- Author
-
Steffens, Younès, Le Bon, Serge-Daniel, Lechien, Jerome, Prunier, Léa, Rodriguez, Alexandra, Saussez, Sven, and Horoi, Mihaela
- Subjects
SMELL disorders ,COVID-19 ,THRESHOLD (Perception) ,PLATELET-rich plasma ,SYMPTOMS - Abstract
Introduction: Olfactory dysfunction (OD) is a well know symptom of coronavirus disease 2019 (COVID-19), accounting for 48 to 85% of patients. In 1 to 10% of cases, patients develop a chronic olfactory dysfunction (COD), lasting more than 6 months. Recently, platelet-rich plasma (PRP) was used in patients with non-COVID-19 COD and authors reported encouraging results. Methods: In the present study, we investigated the usefulness and safety of PRP injection in 56 patients with COVID-19 COD by the Sniffing Stick test (TDI score) and a linker-scale from 0 (none) to 3 (strong) and we compare the result to a control group. Results: At 1 month post-PRP injection, the mean TDI scores significantly improved by 6.7 points in the PRP group (p < 0,001), the mean self-assessment of improvement in smell function was 1.8 (mild-to-moderate) in the PRP group, which was significantly higher than the score (0.3) in the control group (p < 0,001). Conclusion: Our results showed that PRP in the olfactory cleft can increase the olfactory threshold 1 month after the injection. Moreover, our results suggest that timing of treatment may be an important factor and that PRP is a safe treatment, because no adverse effects were reported throughout the study. Trial registration number: NCT05226546. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
11. Making scents of loss of taste in COVID‐19: Is self‐reported loss of taste due to olfactory dysfunction? A prospective study using psychophysical testing.
- Author
-
Le Bon, Serge‐Daniel, Payen, Léa, Prunier, Léa, Steffens, Younès, Horoi, Mihaela, Vaira, Luigi Angelo, Hopkins, Claire, Lechien, Jérôme R., and Saussez, Sven
- Published
- 2021
- Full Text
- View/download PDF
12. Does Pepsin Saliva Concentration (Peptest™) Predict the Therapeutic Response of Laryngopharyngeal Reflux Patients?
- Author
-
Lechien, Jerome R., Bobin, Francois, Dequanter, Didier, Rodriguez, Alexandra, Le Bon, Serge, Horoi, Mihaela, Thill, Marie-Paule, Salem, Charelle, Muls, Vinciane, and Saussez, Sven
- Subjects
SALIVA analysis ,PREDICTIVE tests ,PEPSIN ,TIME ,HEALTH status indicators ,GASTROESOPHAGEAL reflux ,COMPARATIVE studies ,TREATMENT effectiveness ,LARYNGEAL diseases ,DESCRIPTIVE statistics - Abstract
Objective: To study the profile and the therapeutic response of patients with laryngopharyngeal reflux (LPR) at the hypopharyngeal-esophageal multichannel intraluminal impedance-pH monitoring (HEMII-pH) according to the initial pepsin saliva concentration. Methods: From January 2018 to January 2020, patients with positive LPR diagnosis at the HEMII-pH were consecutively recruited from 3 European Hospitals. Saliva pepsin concentration (Peptest™) was measured during the HEMII-pH testing period and patients were classified into 2 groups: negative versus positive Peptest. The clinical outcomes, that is, gastrointestinal and HEMII-pH findings, reflux symptom score-12 (RSS-12), and 3-month therapeutic response, were compared between groups. Results: A total of 124 patients completed the study. Among them, 30 patients had negative Peptest. Pharyngeal reflux events occurred outside 1-hour post-meal time in 74.0%, after the meals in 20.5% and nighttime in 5.5%. The pepsin saliva level was not significantly associated with the reflux events preceding the sample collection. Patients with positive Peptest had better improvement of RSS-12 digestive and respiratory subscores and oral, pharyngeal, and laryngeal findings compared with patients with negative Peptest. Conclusion: Patients with high saliva pepsin concentration had no stronger gastrointestinal, HEMII-pH, or clinical outcomes compared with those with low or undetectable saliva pepsin concentration. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. Association Between Laryngopharyngeal Reflux and Media Otitis: A Systematic Review.
- Author
-
Lechien, Jerome R., Hans, Stéphane, Simon, Francois, Horoi, Mihaela, Calvo-Henriquez, Christian, Chiesa-Estomba, Carlos M, Mayo-Yáñez, Miguel, Bartel, Ricardo, Piersiala, Krzysztof, Nguyen, Yann, and Saussez, Sven
- Published
- 2021
- Full Text
- View/download PDF
14. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell.
- Author
-
Le Bon, Serge-Daniel, Konopnicki, Deborah, Pisarski, Nathalie, Prunier, Léa, Lechien, Jérôme R., and Horoi, Mihaela
- Subjects
SMELL disorders ,CORTICOSTEROIDS ,COVID-19 pandemic ,COVID-19 ,SMELL ,SYMPTOMS - Abstract
Purpose: As the COVID-19 pandemic continues, an increasing number of patients are afflicted by olfactory loss, a now well-recognized symptom of the disease. Though many patients seem to recover their sense of smell after a few weeks, a certain proportion of them seem to develop long-lasting olfactory disorder. Yet, as of October 2020, there is no recommended standardized treatment to reduce the risk of developing long-term olfactory disorder. In this pilot study, we investigated the efficacy and the safety of oral corticosteroids and olfactory training as a treatment for patients with persistent olfactory dysfunction as a result of COVID-19. Methods: Non-hospitalized patients with a sudden loss of smell and a confirmed COVID-19 diagnosis were recruited by hospital call from February to April 2020. These participants were submitted to an extensive psychophysical testing in order to identify those with persistent dysosmia. Dysosmic patients were then treated either by a 10-day course of oral corticosteroids combined with olfactory training, or by olfactory training alone. All participants were subject to a second olfactory test after a mean of 10 weeks. Results: 72 subjects with documented COVID-19 infection performed the initial olfactory test, on average 5 weeks after losing their sense of smell. Amongst them, 27 (37.5%) patients showed persistent dysosmia and were all included in this study. Nine participants received oral corticosteroids and performed olfactory training (OCS + OT), while 18 performed olfactory training (OT) only. Only participants in the OCS + OT group had significantly improved their olfactory score and did so above the minimal clinically important difference for subjective improvement of smell (p = 0.007). Three of the participants who received oral corticosteroids reported minimal and transient side effects. Conclusion: This pilot study may suggest the combination of a short course of oral corticosteroids and olfactory training is safe and may be beneficial in helping patients with enduring dysosmia recover from olfactory loss due to COVID-19. There is a crucial need for further investigation with larger cohorts to corroborate these findings. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
15. Changes of Laryngeal and Extralaryngeal Symptoms and Findings in Laryngopharyngeal Reflux Patients.
- Author
-
Lechien, Jérôme R., Bobin, Francois, Muls, Vinciane, Mouawad, Francois, Dapri, Giovanni, Dequanter, Didier, Horoi, Mihaela, Thill, Marie‐Paule, Rodriguez Ruiz, Alexandra, Saussez, Sven, and Thill, Marie-Paule
- Abstract
Objectives/hypothesis: To assess the evolution of laryngeal and extralaryngeal symptoms and findings of laryngopharyngeal reflux (LPR) throughout a 3-month to 9-month treatment.Study Design: Prospective Controlled Study.Methods: One hundred twenty-seven LPR patients and 123 healthy individuals were enrolled from four European hospitals. Patients were managed with a 3-month personalized treatment considering the LPR characteristics at the impedance-pH monitoring. Regarding the clinical therapeutic response, treatment was adapted for 3 to 6 additional months. Symptoms and findings were assessed throughout the therapeutic course with the Reflux Symptom Score (RSS) and the short version of the Reflux Sign Assessment (sRSA). The relationship between patient and reflux characteristics, symptoms, and findings was assessed.Results: One hundred twenty-one LPR patients completed the study. LPR patients exhibited more laryngeal and extralaryngeal symptoms and findings than healthy individuals. RSS significantly improved from baseline to 6 weeks posttreatment and continued to improve from 3 months to 6 months posttreatment. sRSA significantly improved from baseline to 3 months posttreatment. No further improvement was noted at 6 months posttreatment for pharyngeal and oral findings. Laryngeal findings continued to improve from 3 months to 6 months posttreatment. There was a significant association between patient stress level and RSS (P = .045). At 3 months posttreatment, 28.1% of patients had high or complete response, whereas 47.1% required 6 months or 9 months of treatment. Overall, 24.8% of patients had an LPR chronic course.Conclusions: Laryngeal and extralaryngeal symptoms and findings significantly improved throughout treatment in LPR patients. The improvement of laryngeal findings was slower. Regarding the low prevalence of some digestive or otolaryngological symptoms, a short version of the RSS could be developed.Level Of Evidence: 3 Laryngoscope, 131:1332-1342, 2021. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
16. The efficacy of a personalised treatment depending on the characteristics of reflux at multichannel intraluminal impedance‐pH monitoring in patients with acid, non‐acid and mixed laryngopharyngeal reflux.
- Author
-
Lechien, Jérôme R., Bobin, Francois, Muls, Vinciane, Mouawad, Francois, Dequanter, Didier, Horoi, Mihaela, Thill, Marie‐Paule, Rodriguez Ruiz, Alexandra, and Saussez, Sven
- Subjects
PATIENT monitoring ,TREATMENT effectiveness ,ACIDS ,ALGINIC acid ,SYMPTOMS - Abstract
Objective: To assess the evolution of symptoms and findings of laryngopharyngeal reflux (LPR) patients according to the type of reflux (acid, non‐acid, mixed and gastro‐oesophageal (GERD)). Design: Prospective uncontrolled multicentre study. Methods: One hundred and six patients with LPR have been recruited from 3 European Hospitals. According to the reflux characteristics at the impedance‐pH monitoring (acid, non‐acid, mixed, GERD), patients received a personalised treatment based on the association of diet, pantoprazole, alginate or magaldrate for 3 months. Reflux Symptom Score (RSS) was assessed at baseline, 6 and 12 weeks post‐treatment. Reflux Sign Assessment (RSA) has been used to rate laryngeal and extra‐laryngeal findings at baseline and 12 weeks post‐treatment. Overall success rate and the evolution of symptoms and findings were evaluated according to the LPR types. Results: One hundred and two LPR patients (42 acid, 33 non‐acid, 27 mixed, including 49 with LPR and GERD) completed the study. RSS and RSA total scores significantly improved from baseline to post‐treatment time in acid, mixed and non‐acid groups. The presence of GERD in addition to LPR did not impact the clinical improvement. The 3‐month success rates of treatment ranged from 62% to 64%, and there were no significant differences between groups. The success rate of patients with non‐acid LPR was similar to those of patients with mixed and acid LPR. Conclusion: MII‐pH is useful to specify the type of LPR and the related most adequate therapeutic regimen. Non‐acid or mixed LPR similarly respond to treatment than acid LPR but require a treatment based on alginate or magaldrate covering the non‐acid proximal reflux events. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
17. Hypopharyngeal-Esophageal Impedance-pH Monitoring Profiles of Laryngopharyngeal Reflux Patients.
- Author
-
Lechien, Jerome R., Bobin, Francois, Dapri, Giovanni, Eisendrath, Pierre, Salem, Charelle, Mouawad, Francois, Horoi, Mihaela, Thill, Marie‐Paule, Dequanter, Didier, Rodriguez, Alexandra, Muls, Vinciane, Saussez, Sven, and Thill, Marie-Paule
- Abstract
Objectives/hypothesis: To investigate the profile of patients with laryngopharyngeal reflux (LPR) at hypopharyngeal-esophageal multichannel intraluminal impedance-pH (HEMII-pH) monitoring and the relationship between hypopharyngeal-proximal reflux episodes (HREs) and saliva pepsin concentration.Study Design: Prospective non-controlled.Methods: Patients were recruited from three European hospitals from January 2018 to October 2019. Patients benefited from HEMII-pH monitoring and saliva collections to measure saliva pepsin concentration in the same time. Saliva pepsin concentration was measured in the morning (fasting), after lunch, and after dinner. The LPR profile of patients was studied through a breakdown of the HEMII-pH findings over the 24 hours of testing. The relationship between the concentrations of saliva pepsin and 24-hour HREs was studied through linear multiple regression.Results: One hundred twenty-six patients completed the study. The HEMII-pH analyses revealed that 73.99% of HREs occurred outside 1-hour postmeal times, whereas 20.49% and 5.52% of HREs occurred during the 1-hour postmeal and nighttime, respectively. Seventy-four patients (58.73%) did not have nighttime HREs. Patients with both daytime and nighttime HREs had more severe HEMII-pH parameters and reflux symptom score compared with patients with only daytime HREs. There were no significant associations between HREs and saliva pepsin concentration.Conclusions: Unlike gastroesophageal reflux disease, HREs occur less frequently after meals and nighttime. The analysis of the HEMII-pH profile of the LPR patients has to be considered to develop future personalized therapeutic strategies.Level Of Evidence: 4 Laryngoscope, 131:268-276, 2021. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
18. Saliva Pepsin Concentration of Laryngopharyngeal Reflux Patients Is Influenced by Meals Consumed Before the Samples.
- Author
-
Lechien, Jerome R., Bobin, Francois, Muls, Vinciane, Horoi, Mihaela, Thill, Marie‐Paule, Dequanter, Didier, Finck, Camille, Rodriguez, Alexandra, Saussez, Sven, and Thill, Marie-Paule
- Abstract
Objectives/hypothesis: To assess the impact of diet on the saliva pepsin concentration of patients with laryngopharyngeal reflux (LPR).Study Design: Non-controlled Prospective Study.Methods: Patients with positive LPR regarding hypopharyngeal-esophageal impedance-pH monitoring (HEMII-pH) were enrolled from three European Hospitals. Patients collected three saliva samples, respectively, in the morning (fasting), and 1 to 2 hour after lunch and dinner. Patients carefully detailed foods and beverages consumed during meals and before the pepsin samples. The 3-month treatment was based on the association of diet, proton pump inhibitors, alginate, or magaldrate regarding the HEMII-pH characteristics. Reflux Symptom Score (RSS) and Reflux Sign Assessment (RSA) were used for assessing the pre- to posttreatment clinical evolution. The Refluxogenic Diet Score and the Refluxogenic Score of a Dish (RESDI) were used to assess the refluxogenic potential of foods and beverages. The relationship between saliva pepsin concentration, HEMII-pH, RESDI, RSS, and RSA was investigated through multiple linear regression.Results: Forty-two patients were included. The saliva pepsin concentration of the 24-hour period of testing was significantly associated with foods and beverages consumed during the testing period and the evening dinner (rs = 0.973, P < .001). RSS and RSA significantly improved throughout treatment. The level of saliva pepsin in the morning was a negative predictive factor of the therapeutic response regarding RSA and RSS (P < .036).Conclusions: Foods and beverages may significantly impact the saliva pepsin concentration of patients with LPR. Patients with high-level saliva pepsin in the morning had lower therapeutic response compared with those with low-level saliva pepsin.Level Of Evidence: 4 Laryngoscope, 131:350-359, 2021. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
19. Unilateral chronic maxillary rhinosinusitis after bone maxillary graft for dental implant placement: A case report.
- Author
-
Lechien, Jerome R., Lamartine Monteiro, Raquel, Kampouridis, Stelianos, Javadian, Rokneddine, and Horoi, Mihaela
- Subjects
DENTAL implants ,BONE grafting ,SINUSITIS - Abstract
Odontogenic chronic maxillary rhinosinusitis has to be suspected in patient with a history of dental implant placement just after bone maxillary graft. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
20. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019.
- Author
-
Lechien, Jerome R., Chiesa‐Estomba, Carlos M., Place, Sammy, Van Laethem, Yves, Cabaraux, Pierre, Mat, Quentin, Huet, Kathy, Plzak, Jan, Horoi, Mihaela, Hans, Stéphane, Rosaria Barillari, Maria, Cammaroto, Giovanni, Fakhry, Nicolas, Martiny, Delphine, Ayad, Tareck, Jouffe, Lionel, Hopkins, Claire, Saussez, Sven, Blecic, Serge, and De Siati, Daniele R.
- Subjects
COVID-19 ,SMELL disorders ,SEXUAL dimorphism ,SYMPTOMS ,APPETITE loss ,BAYESIAN analysis ,VIRAL pneumonia ,TASTE disorders ,MYALGIA ,AGE distribution ,SEX distribution ,DISEASE prevalence ,EPIDEMICS ,HEADACHE ,PROBABILITY theory ,DISEASE complications - Abstract
Background: The clinical presentation of European patients with mild-to-moderate COVID-19 infection is still unknown.Objective: To study the clinical presentation of COVID-19 in Europe.Methods: Patients with positive diagnosis of COVID-19 were recruited from 18 European hospitals. Epidemiological and clinical data were obtained through a standardized questionnaire. Bayesian analysis was used for analysing the relationship between outcomes.Results: A total of 1,420 patients completed the study (962 females, 30.7% of healthcare workers). The mean age of patients was 39.17 ± 12.09 years. The most common symptoms were headache (70.3%), loss of smell (70.2%), nasal obstruction (67.8%), cough (63.2%), asthenia (63.3%), myalgia (62.5%), rhinorrhea (60.1%), gustatory dysfunction (54.2%) and sore throat (52.9%). Fever was reported by 45.4%. The mean duration of COVID-19 symptoms of mild-to-moderate cured patients was 11.5 ± 5.7 days. The prevalence of symptoms significantly varied according to age and sex. Young patients more frequently had ear, nose and throat complaints, whereas elderly individuals often presented fever, fatigue and loss of appetite. Loss of smell, headache, nasal obstruction and fatigue were more prevalent in female patients. The loss of smell was a key symptom of mild-to-moderate COVID-19 patients and was not associated with nasal obstruction and rhinorrhea. Loss of smell persisted at least 7 days after the disease in 37.5% of cured patients.Conclusion: The clinical presentation of mild-to-moderate COVID-19 substantially varies according to the age and the sex characteristics of patients. Olfactory dysfunction seems to be an important underestimated symptom of mild-to-moderate COVID-19 that needs to be recognized as such by the WHO. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
21. Chondrolaryngoplasty for transgender patients: feasibility of a scar-free approach.
- Author
-
Verhasselt, Marie, Cavelier, Gaëtan, Horoi, Mihaela, Dequanter, Didier, and Rodriguez, Alejandra
- Subjects
TRACHEAL cartilage ,THYROID gland ,FEASIBILITY studies ,THYROIDECTOMY - Abstract
Purpose: Adult male-to-female transgender patients with a prominent thyroid notch can benefit from chondrolaryngoplasty with high satisfaction rates. It is a safe, effective, and established procedure with only minor and temporary complications. Until now, only external approaches have been described, leaving the patient with a cervical scar, which remains a frequent complaint. The goal of this study is to assess the feasibility of a transvestibular endoscopic chondrolaryngoplasty. Methods: Transvestibular endoscopic chondrolaryngoplasty was conducted on six fresh adult male cadavers. The thyroid cartilage approach was similar to the one described in cases of transvestibular endoscopic thyroidectomy. After thyroid notch exposition, the laryngeal prominence was shaved down using an endoscopic burr until the desired aesthetic result was achieved. Results: Laryngeal prominence volume was significantly reduced without any cutaneous scar. Conclusion: We have demonstrated that this novel approach is feasible and has the advantage of leaving the patient's neck scar-free. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
22. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.
- Author
-
Lechien, Jerome R., Chiesa-Estomba, Carlos M., De Siati, Daniele R., Horoi, Mihaela, Le Bon, Serge D., Rodriguez, Alexandra, Dequanter, Didier, Blecic, Serge, El Afia, Fahd, Distinguin, Lea, Chekkoury-Idrissi, Younes, Hans, Stéphane, Delgado, Irene Lopez, Calvo-Henriquez, Christian, Lavigne, Philippe, Falanga, Chiara, Barillari, Maria Rosaria, Cammaroto, Giovanni, Khalife, Mohamad, and Leich, Pierre
- Subjects
SMELL disorders ,COVID-19 ,HEALTH & Nutrition Examination Survey ,SYMPTOMS - Abstract
Objective: To investigate the occurrence of olfactory and gustatory dysfunctions in patients with laboratory-confirmed COVID-19 infection. Methods: Patients with laboratory-confirmed COVID-19 infection were recruited from 12 European hospitals. The following epidemiological and clinical outcomes have been studied: age, sex, ethnicity, comorbidities, and general and otolaryngological symptoms. Patients completed olfactory and gustatory questionnaires based on the smell and taste component of the National Health and Nutrition Examination Survey, and the short version of the Questionnaire of Olfactory Disorders-Negative Statements (sQOD-NS). Results: A total of 417 mild-to-moderate COVID-19 patients completed the study (263 females). The most prevalent general symptoms consisted of cough, myalgia, and loss of appetite. Face pain and nasal obstruction were the most disease-related otolaryngological symptoms. 85.6% and 88.0% of patients reported olfactory and gustatory dysfunctions, respectively. There was a significant association between both disorders (p < 0.001). Olfactory dysfunction (OD) appeared before the other symptoms in 11.8% of cases. The sQO-NS scores were significantly lower in patients with anosmia compared with normosmic or hyposmic individuals (p = 0.001). Among the 18.2% of patients without nasal obstruction or rhinorrhea, 79.7% were hyposmic or anosmic. The early olfactory recovery rate was 44.0%. Females were significantly more affected by olfactory and gustatory dysfunctions than males (p = 0.001). Conclusion: Olfactory and gustatory disorders are prevalent symptoms in European COVID-19 patients, who may not have nasal symptoms. The sudden anosmia or ageusia need to be recognized by the international scientific community as important symptoms of the COVID-19 infection. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
23. Gastroesophageal reflux in laryngopharyngeal reflux patients: Clinical features and therapeutic response.
- Author
-
Lechien, Jerome R., Bobin, Francois, Muls, Vinciane, Eisendrath, Pierre, Horoi, Mihaela, Thill, Marie‐Paule, Dequanter, Didier, Durdurez, Jean‐Pierre, Rodriguez, Alexandra, Saussez, Sven, Thill, Marie-Paule, and Durdurez, Jean-Pierre
- Abstract
Objective: To investigate the clinical features and the therapeutic response of laryngopharyngeal reflux (LPR) patients with or without gastroesophageal reflux disease (GERD).Methods: Patients with LPR symptoms were enrolled from three European Hospitals. The diagnosis of LPR and GERD was made through impedance-pH monitoring (MII-pH). A gastrointestinal endoscopy was realized in patients with digestive complaints or ≥60 years old. The 3- to 6-month treatment was based on the association of diet, pantoprazole, alginate, and magaldrate regarding the MII-pH characteristics. Reflux Symptom Score (RSS) and Reflux Sign Assessment (RSA) were used to evaluate the clinical evolution throughout treatment. The gastrointestinal endoscopy findings, clinical features, and therapeutic response were compared between patients with LPR and GERD (LPR/GERD) and patients with LPR.Results: One hundred and eleven LPR patients were included, 54 being LPR/GERD. LPR/GERD patients had a higher number of proximal reflux episodes compared with LPR patients. The prevalence of esophagitis, hernia hiatal, and lower esophageal sphincter insufficiency did not differ between groups. The presence of GERD was strongly associated with acid LPR. Patients without GERD had a higher proportion of nonacid and mixed LPR compared with LPR/GERD patients. The pre- to posttreatment evolutions of RSS and RSA were quite similar in both groups, with the exception of the 3- to 6-month improvement of digestive symptoms, which was better in LPR/GERD group. The therapeutic success rates were 79.6% and 77.2% in GERD/LPR and LPR group, respectively.Conclusion: GERD is predictive of acid LPR. The clinical evolution and the therapeutic response rates were quite similar in both groups.Level Of Evidence: 4 Laryngoscope, 130: E479-E489, 2020. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
24. Intranasal trigeminal training in empty nose syndrome: A pilot study on 14 patients.
- Author
-
Le Bon, Serge‐Daniel, Horoi, Mihaela, Le Bon, Olivier, and Hassid, Sergio
- Subjects
- *
PILOT projects , *NOSE - Abstract
Empty nose syndrome is a rare and debilitating complication of turbinate surgery, with varying symptoms of which paradoxical nasal obstruction is typical. Medical histories revealed surgery on inferior turbinates in 13 patients and on middle turbinates in one patient. Moreover, these surgeries concern patients with resected turbinates and do not account for ENS patients who still have turbinates. For future studies, authors recommend adding control groups by comparing ENS patients with healthy individuals and patients with total inferior turbinectomy but no ENS symptoms. [Extracted from the article]
- Published
- 2020
- Full Text
- View/download PDF
25. Validity and reliability of the reflux symptom score.
- Author
-
Lechien, Jérôme R., Bobin, Francois, Muls, Vinciane, Thill, Marie‐Paule, Horoi, Mihaela, Ostermann, Katharina, Huet, Kathy, Harmegnies, Bernard, Dequanter, Didier, Dapri, Giovanni, Maréchal, Marie‐Therese, Finck, Camille, Rodriguez Ruiz, Alexandra, Saussez, Sven, Thill, Marie-Paule, and Maréchal, Marie-Therese
- Abstract
Objectives/hypothesis: To develop and validate the Reflux Symptom Score (RSS), a self-administered patient-reported outcome questionnaire for patients with laryngopharyngeal reflux (LPR).Study Design: Prospective controlled study.Methods: A total of 113 patients with LPR were enrolled and treated with diet and 3 months of pantoprazole, alginate, and/or magaldrate depending on the LPR characteristics (acid, nonacid, or mixed). Eighty asymptomatic individuals completed the study. Patients and controls completed the RSS twice within a 7-day period to assess test-retest reliability. Internal consistency was measured using Cronbach's α for the RSS items in patients and controls. Validity was assessed by comparing the baseline RSS with the Reflux Symptom Index (RSI) and Voice Handicap Index (VHI). Seventy-seven patients completed the RSS at baseline and after 6 and 12 weeks of treatment to assess responsiveness to change. The RSS cutoff for determining the presence and absence of LPR was examined by receiver operating characteristic analysis.Results: Test-retest reliability (rs = 0.921) and internal consistency reliability (α = 0.969) were high. RSS exhibited high external validity indicated by a significant correlation with the RSI (rs = 0.831). Internal validity was excellent based on the higher RSS in patients compared with controls (P = .001). RSS, RSI, and VHI scores significantly improved from pre- to posttreatment, indicating a high responsiveness to change. RSS >13 can be considered suggestive of LPR-related symptoms. RSS was not influenced by the occurrence of gastroesophageal reflux disease, LPR subtypes, or patient characteristics.Conclusions: RSS is a self-administered patient-reported outcome questionnaire that demonstrates high reliability and excellent criterion-based validity. RSS can be used in diagnosing and monitoring LPR disease.Level Of Evidence: 3b Laryngoscope, 130:E98-E107, 2020. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
26. Hearing aid and Koebner phenomenon.
- Author
-
Lechien, Jérôme R., Scheers, Christel, Horoi, Mihaela, and Thill, Marie‐Paule
- Subjects
HEARING aids ,EXTERNAL ear ,SKIN - Abstract
Koebner phenomenon may be related to frictions of a hearing aid on the external ear and retroauricular skin. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
27. Case report: Ultrasound diagnosis of fish bone penetration into the thyroid.
- Author
-
Cavelier, Gaëtan, Ostermann, Katharina, Horoi, Mihaela, Huvenne, Raymond, Dequanter, Didier, and Rodriguez, Alexandra
- Subjects
FISHES ,THYROID gland ,DIAGNOSIS ,ULTRASONIC imaging - Abstract
Key Clinical Message: Ultrasonography is useful in the diagnosis of foreign body migrations (eg, fish bones) into the soft tissues of the neck. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
28. Chronic maxillary atelectasis and silent sinus syndrome: two faces of the same clinical entity.
- Author
-
Dorlodot, Clotilde, Collet, Stephanie, Rombaux, Philippe, Horoi, Mihaela, Hassid, Sergio, and Eloy, Philippe
- Subjects
ATELECTASIS ,MAXILLARY sinus diseases ,PATHOLOGICAL physiology ,COMPUTED tomography ,RETROSPECTIVE studies ,DIAGNOSIS - Abstract
Chronic maxillary atelectasis (CMA) and silent sinus syndrome (SSS) are rare clinical entities characterized by an implosion of the maxillary sinus that may or may not be associated with sinonasal symptoms, and are complicated by ipsilateral enophthalmos. The objective of this article is to discuss the definitions, physiopathology, clinical and radiographic characteristics, and surgical management of these entities. We retrospectively reviewed 18 patients (7 women, 11 men, aged 12-70 years) diagnosed and treated in the ear, nose, and throat departments of four Belgian teaching hospitals between 2000 and 2015. Nine patients had a history of sinus disease. In all cases, a computed tomography scan showed downward displacement of the orbital floor, increased orbital volume, and maxillary sinus contraction. Five patients met the criteria for grade II CMA and 13 for grade III CMA. Four patients met the criteria for SSS. All patients underwent wide endoscopic middle maxillary antrostomy. There were no orbital complications and all patients experienced resolution or a dramatic reduction of their symptomatology. Only one patient asked for an orbital floor reconstruction to correct a persisting cosmetic deformity. Although CMA and SSS are usually regarded as different entities in the literature, we believe that they lie on the same clinical spectrum. Treatment for both conditions is similar, i.e., middle meatal antrostomy to halt or even reverse the pathological evolution and reconstruction of the orbital floor in the event of persistent cosmetic deformity. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
29. Rare anatomic variation: Nasopharyngeal middle turbinate.
- Author
-
Lechien, Jérôme R., Rodriguez, Alexandra, Kampouridis, Stelianos, and Horoi, Mihaela
- Subjects
SINUSITIS ,NASOPHARYNX - Abstract
Nasopharyngeal middle turbinate may be not systematically associated with recurrent chronic rhinosinusitis and could be indolent. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
30. Galectin fingerprinting in naso-sinusal diseases.
- Author
-
DURAY, ANAËLLE, DE MAESSCHALCK, THIBAULT, DECAESTECKER, CHRISTINE, REMMELINK, MYRIAM, CHANTRAIN, GILBERT, NEIVEYANS, JENNIFER, HOROI, MIHAELA, LEROY, XAVIER, GABIUS, HANS-JOACHIM, and SAUSSEZ, SVEN
- Published
- 2014
- Full Text
- View/download PDF
31. An Unexpected Complication of Transsphenoidal Resection of Pituitary Adenoma.
- Author
-
Lechien, Jérôme R., Kampouridis, Stelianos, Le Bon, Serge D., Thill, Marie-Paule, and Horoi, Mihaela
- Subjects
SURGICAL complication risk factors ,COMPUTED tomography ,ENDOSCOPY ,GASTRECTOMY ,MAGNETIC resonance imaging ,OPERATIVE otolaryngology ,PITUITARY tumors ,RISK assessment ,SPHENOID sinus ,TREATMENT effectiveness - Abstract
The article presents a case of a 31-year old migrant patient which experienced an unexpected complication of transsphenoidal resection of pituitary adenoma. Topics covered include the complaints reported by the patient after his second endoscopic surgical procedure for a pituitary prolactinoma in Africa, the findings of the tympanoscopy, tympanometry and audiometry performed on the patient and the most reported postoperative complications of transsphenoidal surgery.
- Published
- 2020
- Full Text
- View/download PDF
32. A 10-Year Follow-Up of a Randomized Prospective Study of 2 Treatments for Chronic Rhinosinusitis Without Nasal Polyps and Investigation of the Impact of Gastroeosophageal Reflux Disease in the Resistance to Treatment.
- Author
-
Lechien, Jerome R., Debie, Gersende, Mahillon, Virginie, Thill, Marie-Paule, Rodriguez, Alexandra, Horoi, Mihaela, Kampouridis, Stelianos, Muls, Vinciane, and Saussez, Sven
- Subjects
PARANASAL sinus surgery ,NASAL polyps ,NATURAL immunity ,EVALUATION of medical care ,CLAVULANIC acid ,STEROIDS ,CLARITHROMYCIN ,GASTROESOPHAGEAL reflux ,TREATMENT failure ,COMPARATIVE studies ,DISEASE relapse ,SINUSITIS ,QUESTIONNAIRES ,DRUG side effects ,HELICOBACTER diseases ,AMOXICILLIN - Abstract
Objectives: To compare the 2 long-term medical strategies in chronic rhinosinusitis without nasal polyps (CRSnNP) and to identify the role of gastroesophageal reflux disease (GERD) and Helicobacter pylori as factors of treatment failure. Material and Methods: Fifty-seven patients with CRSnNP were randomized into 2 therapeutic groups. The first group was treated with 4 weeks of amoxicillin/clavulanate and a short course of oral steroids. The second group received 8 weeks of clarithromycin. Sinonasal Outcome Test-20 (SNOT-20) and Lund and Mackay scores were assessed at baseline and after treatment, and GERD Health-Related Quality of Life (GERD-HRQL) questionnaire was evaluated in all patients. Patients with a GERD-HRQL score >8 received esogastroscopy and H pylori detection. Patients were followed during a 10-year period for clinical course and GERD evolution. The 10-year evolution of patients was described in terms of recurrence, medical, and surgical treatments. Results: Thirty-seven patients completed the study; SNOT-20 and Lund and Mackay scores similarly improved in both groups. Amoxicillin/clavulanate group had significantly more adverse reactions than the clarithromycin group (P =.03). After the therapeutic course, 35% (amoxicillin/clavulanate) and 41% (clarithromycin) of patients needed functional endoscopic sinus surgery (FESS). During the long-term follow-up, 54% (amoxicillin/clavulanate) and 40% (clarithromycin) of patients had late CRSnNP recurrence; FESS was performed in less than 15% of cases of recurrence. Gastroesophageal reflux disease complaint's severity was associated with late recurrence of CRSnNP. Conclusion: Amoxicillin/clavulanate and clarithromycin would be competitive treatments for CRSnNP. Gastroesophageal reflux disease seems to be a negative factor for treatment response and recurrence. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
33. Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study.
- Author
-
Saussez, Sven, Vaira, Luigi Angelo, Chiesa-Estomba, Carlos M., Bon, Serge-D. Le, Horoi, Mihaela, Deiana, Giovanna, Petrocelli, Marzia, Boelpaep, Philippe, Salzano, Giovanni, Khalife, Mohamad, Hans, Stephane, De Riu, Giacomo, Hopkins, Claire, and Lechien, Jerome R.
- Subjects
COVID-19 ,SMELL disorders ,COVID-19 treatment ,COVID-19 pandemic ,SAFETY ,RANDOMIZED controlled trials ,COVID-19 testing - Abstract
Background: The objective of this study was to investigate the efficacy and safety of early administration of oral corticosteroids (OC) or nasal corticosteroids (NC) as an add-on to olfactory training (OT) versus OT alone in patients with olfactory dysfunction (OD) related to coronavirus disease 2019 (COVID-19). Methods: Patients with a positive diagnosis of COVID-19 and OD were prospectively recruited from March 22 to December 15, 2020 from 4 European hospitals. Patients had confirmed OD on psychophysical testing. All patients undertook OT, with add-on 10 days of OC (group 1: OC + OT), or 1 month of NC (group 2: NC + OT) or olfactory training alone (group 3: OT). Olfactory evaluations (Sniffin'Sticks tests) were carried out at the time of inclusion, 1 and 2 months after the start of the therapeutic course. Results: A total of 152 hyposmic or anosmic patients completed the study. Group 1, 2 and 3 included 59, 22 and 71 patients, respectively and all patient groups were comparable regarding baseline Sniffin'Sticks tests. The median Sniffin'Sticks test values significantly improved from pre- to post-intervention in all groups. The increase of Sniffin'Sticks test values was higher in group 1 (OC + OT) compared with groups 2 and 3 (p < 0.001) at one month after treatment but did not remain so at 2 months. Groups 1, 2 and 3, respectively, presented parosmia in 20/71 (28.2%), 9/22 (40.9%) and 42/71 (59.2%) patients. This difference was statistically significant between group 1 and 3 (p < 0.001). There were no patients with a worsening of the disease or an increase of the severity of the COVID-19 symptoms. Conclusions: The use of OCs in patients with OD related to mild COVID-19 is generally well-tolerated without any case of deterioration of symptoms. OC is associated with greater improvement in psychophysical olfactory evaluations at 1-month post-treatment but there was no difference at 2 months. Parosmia may be reduced following treatment with OC and NC. On the basis of these preliminary results, it is possible to state that considering the 2 months efficacy of OC and NC with respect to the OT alone and the risk-benefit ratio, the benefit to start a specific treatment of COVID-19 related OD cannot be demonstrated and there is a need for a randomised controlled trial to assess this further. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
34. Central Vertigo and Hearing Loss in an African Swimmer.
- Author
-
Lechien, Jérôme R., Horoi, Mihaela, and Kampouridis, Stelianos
- Published
- 2019
- Full Text
- View/download PDF
35. Cochlear Implantation in Refsum Disease with Facial Nerve Enlargement.
- Author
-
Horoi, Mihaela, Kampouridis, Stelianos, Sennaroglu, Levent, and Thill, Marie-Paule
- Published
- 2019
- Full Text
- View/download PDF
36. BASELINE SNOT-22 AS OUTCOME PREDICTOR: A POWERFUL TOOL JUST AT HAND.
- Author
-
Rogister, Florence, De Dorlodot, Clotilde, Ansari, Edward, Horoi, Mihaela, Lefebvre, Philippe, Eloy, Philippe, and Poirrier, Anne-Lise
- Published
- 2018
37. Impact of COVID-19 Lockdown on Stress and Diet Adherence in Patients with Laryngopharyngeal Reflux.
- Author
-
LECHIEN, Jerome R., STEFFENS, Younes, CALVO-HENRIQUEZ, Christian, Mayo-YANEZ, Miguel, HOROI, Mihaela, and RODRIGUEZ, Alexandra
- Subjects
- *
PATIENT compliance , *STAY-at-home orders , *PERCEIVED Stress Scale , *DIET , *HYPOPHARYNGEAL cancer , *PROTON pump inhibitors , *CELIAC disease - Abstract
Objectives: To study the impact of lockdown on diet adherence and stress in patients treated for laryngopharyngeal reflux (LPR). Methods: Patients with a positive LPR diagnosis at the hypopharyngeal-esophageal impedance-pH monitoring were treated from the pre- to lockdown period with diet, behavioral changes and an association of proton pump inhibitors and alginate. The following outcomes were used to assess the clinical features of patients: reflux symptom score-12 (RSS-12) and reflux sign assessment (RSA). At post-treatment time, patients were invited to evaluate the impact of lockdown on diet adherence and stress management with a predefined grid of foods and beverages and perceived stress scale (PSS), respectively. Results: Thirty-two patients completed the evaluations. RSS-12 and RSA significantly improved from baseline to three-month post-treatment. Most patients experienced mild-to-severe stress level at the end of the lockdown. The level of stress substantially increased in 34% of patients due to lockdown, while it did not change in 44%. In 34% of cases, patients reported that adherence to antireflux diet was better than initially presumed thanks to the lockdown period, while 44% believed that the lockdown did not impact their adherence to diet. PSS and RSS-12 were significantly correlated at the end of the pandemic (p<0.001). The increase of stress level was positively associated with the lack of adherence to diet (p=0.039). Conclusion: During the lockdown, diet habits were improved or unchanged in most LPR cases, while stress level was increased in one-third of patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.